|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 高血压患者肾素血管紧张素系统阻断的血浆分子标志:肾损害与初发蛋白尿的新预测指标显示文摘蛋白尿是一个与心血管病密切相关的危险因素,也是一般人群的首位死亡原因。虽然已经明确肾素血管紧张素系统(renin-angiotensin system,RAS)阻断剂能延缓高血压患者初发蛋白尿进展、减少蛋白尿排出,但仍不能忽视高血压患者发生初发蛋白尿的比例。 | Baldan-Martin M Mourino-Alvarez L Gonzalez-Calero L Moreno-Luna R Sastre-Oliva T Ruiz-Hurtado G Segura J Lopez JA Vazquez J Vivanco F Alvarez-Llamas G Ruilope LM de la Cuesta F Barderas MG 赵狄 练桂丽 | 2016 | 中华高血压杂志2016，24，6： | 2 |
| 2 | Obesity essential hypertension and rennin- angiotensin system显示文摘 | Segura J Ruilope LM | 2007 | Public Health Nutr2007，10，10： | 1 |
| 3 | Ficacy and tolerability of combination therapy with valsartan plus hydrochlorothia-zide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST stady显示文摘 | Ruilope LM Malacco E Khder Y | 2005 | Clln Ther2005，27，5： | 1 |
| 4 | Antihypertensive treatment in patients with type-2 diabetesmeIlitus: what guidance from recent controlled randomized trials? 显示文摘 | Zanchetti A Ruilope LM | 2002 | J Hypertens2002，20，： | 1 |
| 5 | Microalbuminuria显示文摘 | Segura J Ruilope LM Rodicio JL | 2004 | Clin Exp Hypertens2004，26，： | 1 |
| 6 | Hypertension and obesity:correlates with renin-angiotensin-aldosterone system and uric acid显示文摘 | Ruiz-Hurtado G Ruilope LM | 2014 | J Clin Hypertens(Greenwich)2014，16，8： | 1 |
| 7 | Fieaey and tolerability of combination therapy with valsartan plus hydrochlo rothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors:the VAST study显示文摘 | Ruilope LM Malaeeo E Khder Y | 2005 | Clin Ther2005，27，5： | 1 |
| 8 | Erectile dysfunction in essential arterial hypertension and effects sildenafil: results of Spanish national study 显示文摘 | Aranda P Ruilope LM Cairo C | 2004 | Am J Hypertens2004，17，2： | 1 |
| 9 | Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria显示文摘 | Bakris GL Ruilope LM McMorn SO | | Journal of Hypertension0，，： | 1 |
| 10 | Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) 显示文摘 | Pitt B Bakris G Ruilope LM | 2008 | Circulation2008，118，16： | 1 |
| 11 | Factors influencing the systolic blood pressure response to drug therapy显示文摘 | Campo C Segura J Ruilope LM | 2002 | J Clin Hypertens(Greenwich)2002，4，1： | 1 |
| 12 | Effect of rimonabant, on blood pressure in overweight/obese patients with/without comorbidities: analysis of pooled RIO study results 显示文摘 | Ruilope LM Despres JP Scheen A | 2008 | J Hypertens2008，26，2： | 1 |
| 13 | 24-hour ambulatory blood-pressure Effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk:a VAST sub-study显示文摘 | Ruilope LM Heintz D Brandao AA | 2005 | Blood Press Monit2005，10，2： | 1 |
| 14 | Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities:analysis of pooled RIO study results显示文摘 | Ruilope LM Despres JP Scheen A | 2008 | J nypertens2008，26，2： | 1 |
| 15 | Uric acid and other renal function parameters in patients with stable angina pectoris participating in the action trial : impact of uifedipine GITS ( gastrointestinal therapeutic system) and relation to outcome 显示文摘 | Ruilope LM Kirwan BA de Brouwer S | 2007 | Hypertens2007，25，： | 1 |
| 16 | Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetic mellitus : a review of the clinical trial evidence显示文摘 | RUILOPE LM SEGURA J | 2003 | Clin Ther2003，25，12： | 1 |
| 17 | Renal protection with an- giotensin receptor blockers: where do we stand 显示文摘 | Schmieder RE Ruilope LM Barnett AH | 2011 | J Nephro12011，24，5： | 1 |
| 18 | Angiotensin receptor blockade in diabetic renal disease focus on eandesartan显示文摘 | Donaire JA Ruilope LM | 2007 | Diabetes Res Clin Pract2007，76，1： | 1 |
| 19 | Blood-pressure reduction with LCZ6%, a novel dual-acting inhibitor of the angiotensin H receptor and neprilysin , a randomised , double-blind, placebo-controlled, active comparator study 显示文摘 | Ruilope LM Dukat A Bchm M | 2010 | Lancet2010，375，： | 1 |
| 20 | Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications 显示文摘 | Sarafidis PA Ruilope LM | 2006 | AM J Nephrol2006，26，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员